Abstract
Background There is a need to expand clinical pharmacy services to cover the ambulatory pediatric cancer patients. There is a paucity of published literature describing pharmacy services in this setting. Objective To describe the development, implementation and the reported interventions of a clinical pharmacy service in the outpatient pediatric hematology–oncology clinics at a comprehensive cancer center in Jordan. Methods A stepwise approach was followed to develop and implement the described service. Four goals were set for the service comprising (1) ensure safe medication use (2) improve patient and caregiver education (3) enhance efficiency in medication distribution (4) facilitate the continuity of care across the inpatient and outpatient settings. The interventions collected were categorized into four major classes: clarification, safety, therapeutic and education. Results A total of 939 interventions were reported. Safety interventions were the highest with 500 (53%), followed by education 247 (26%), clarification 113 (12%) and therapeutic 79 (9%). The most common single interventions were patient counseling 247 (26%) and chemotherapy evaluation 229 (24%). Less frequent interventions were drug interactions and adverse drug reactions with 10 (1%) each. Conclusion Developing pediatric hematology–oncology clinical pharmacy services to cover the outpatient setting is essential to ensure continuity of care and to optimize therapeutics.
This is a preview of subscription content, log in via an institution to check access.
References
Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47:533–43.
Katherine KK, Mark PO, Beverly LB. ASHP survey of ambulatory care pharmacy practice in health systems—2004. Am J Health-Syst Pharm. 2005;62:274–84.
Wong SW, Gray ES. Clinical pharmacy services in oncology clinics. J Oncol Pharm Pract. 1999;5(1):49–54.
Shah S, Dowell J, Greene S. Evaluation of clinical pharmacy services in a haematology/oncology outpatient setting. Ann Pharmacother. 2006;40(9):1527–33.
Ruder AD, Smith DL, Madsen MT, Kass FH. Is there a benefit to having a clinical oncology pharmacist on staff at a community oncology clinic? J Oncol Pharm Pract. 2011; doi:10.1177/1078155210389216 [Epub ahead of print].
Valgus JM, Faso A, Gregory KM, Jarr S, Savage S, Caiola S, et al. Integration of a clinical pharmacist into the hematology–oncology clinics at an academic medical center. Am J Health Syst Pharm. 2011;68(7):613–9.
Crews KR, Cross SJ, McCormick JN, Baker DK, Molinelli AR, Mullins R, Relling MV, Hoffman JM. Development and implementation of a pharmacist-managed clinical pharmacogenetics service. Am J Health Syst Pharm. 2011;68(2):143–50.
Lam MS. Extemporaneous compounding of oral liquid dosage formulations and alternative drug delivery methods for anticancer drugs. Pharmacotherapy. 2011;31(2):164–92.
Kondryn HJ, Edmondson CL, Hill J, Eden TO. Treatment non-adherence in teenage and young adult patients with cancer. Lancet Oncol. 2011;12(1):100–8.
Acknowledgments
None.
Funding
None.
Conflicts of interest
The authors declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Appendix: Chemotherapy pharmaceutical care flow sheet
Appendix: Chemotherapy pharmaceutical care flow sheet
Rights and permissions
About this article
Cite this article
Tuffaha, H.W., Abdelhadi, O. & Omar, S.A. Clinical pharmacy services in the outpatient pediatric oncology clinics at a comprehensive cancer center. Int J Clin Pharm 34, 27–31 (2012). https://doi.org/10.1007/s11096-011-9600-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11096-011-9600-4